RESULTS, FEASIBILITY AND SAFETY IN LAPAROSCOPY ASSISTED TRANSHIATAL ESOPHAGECTOMY

Abstract

Background: The whole laparoscopic method, which has not yet acquired widespread acceptance due to its complexity, is 
also used to treat esophageal cancer. Additionally, there is a dearth of data in the literature regarding LATE for esophageal 
cancer.  
Aim: To evaluate the results, viability, and safety of LATE (laparoscopic-assisted transhiatal esophagectomy) in patients with 
esophageal cancer. 
Methods: During the study period, a single surgical team performed LATE (laparoscopic-assisted transhiatal esophagectomy) 
on 52 patients with esophageal cancer. The study participants ranged in age from 33 to 70, with a mean age of 54.8±2.4 years.  
Results: The average length of hospital stay, blood loss, and operating time were 11.3 days (7–26), 300 milliliters (100–500), 
and 300 minutes (160–650), respectively. Pulmonary problems were observed in 30.7% (n=16) and cervical anastomotic leak 
in 11.5% (n=6) of the individuals, respectively. In 3.84% (n=2), 11.5% (n=6), 38.46% (n=20), and 46.15% (n=24) of the 
individuals, the AJCC staging was IIA, IIB, IIIA, and IIIB.  
Conclusion: The current study comes to the conclusion that LATE (laparoscopic-assisted transhiatal esophagectomy) is a 
safe and practical treatment option for the chosen individuals with lower thoracic esophageal cancer.